J&amp;J arthritis drug poses cancer risk
93502
Company warns Remicade may up risk of lymphoma, label changed for second time to reflect hazards. NEW YORK  - Johnson &amp; Johnson is warning doctors that patients taking its rheumatoid arthritis drug
762997
For the people who have followed closely the unfolding concerns about popular arthritis medicines, the news that Celebrex may also be linked to a higher risk of stroke and heart attack holds little surprise.
87385
Celebrex, an arthritis drug in the same class as the recalled painkiller Vioxx, caused irregular heartbeats in fruit flies and in heart cells taken from laboratory rats, U.S. researchers said on Friday.
171468
NEW YORK  - Newer drugs like Enbrel and  Remicade have been a boon to many arthritis sufferers, but  researchers now report that such drugs may lead to the  development of an inflammatory disorder of blood vessels,  usually affecting the skin.
359683
A Johnson & Johnson JNJ.N  promotion for rheumatoid arthritis drug Remicade is misleading  because it makes unsupported claims about the drug's  effectiveness and omits important information about risks, U.S.  regulators said in a letter released on Monday.
425457
People on anti-HIV drug Viracept are being warned batches of the drug may have been infected with cancer-causing chemicals.
339251
BOSTON - The safety of Celebrex and other pain relievers was questioned Wednesday as scientists in the United States and regulatory agencies in Europe said they feared such drugs might raise the same risk of heart problems as those blamed on the arthritis
633814
NEW YORK  - Women with the autoimmune  disorder systemic lupus erythematosus (SLE) seem to have a  heightened risk for cervical cancer when they're been treated  with the immune-suppressing drug cyclophosphamide, according to  a new study.
534728
Arthritis drugs like Celebrex and the recently withdrawn Vioxx may boost the immune system's ability to attack brain tumors, and possibly other types of cancer, researchers said on Friday.
709067
NEW YORK  - In patients with rheumatoid   arthritis, use of disease-modifying antirheumatic drugs, or   DMARDs, seems to lower the increased risk of cardiovascular   disease associated with rheumatoid arthritis, research   suggests.
90441
The drug maker says a three-year study of the arthritis pain medication demonstrated a higher risk of heart attack and stroke in patients using the drug.
753810
Amid growing concerns, the maker of the widely sold arthritis drug announced Monday that it will soon begin a major clinical trial to determine whether the drug is safe for long-term use.
318514
BLOW TO ANOTHER DRUG: A cancer prevention study found people taking very high doses of the painkiller Celebrex had higher risk of heart problems.
11707
Patients taking Merck & Co. Inc.'s Vioxx arthritis drug had a 50 percent greater chance of heart attacks and sudden cardiac death than individuals using Pfizer Inc.'s rival Celebrex medicine, according to a large study financed by the U.S. Food and Drug Administration.
118762
Celebrex, an arthritis pain reliever used by tens of millions of people, has been found to elevate the risk of heart attack and stroke.
89963
The arthritis drug Remicade may increase users&#39; risk of acquiring lymphatic cancer, manufacturer Centocor Inc. says in a warning letter to physicians announcing a labeling change for the medication.
357920
Pfizer Inc. on Friday said patients  taking its blockbuster arthritis drug Celebrex in a long-term  cancer-prevention trial had more than twice the number of fatal  or non-fatal heart attacks as those taking a placebo.